VP-2.51

N/A

Report date: 2025/03/20 09:32:04
NME

Base Information

Drug NameVP-2.51
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 alpha inhibitors
TargetsGlycogen synthase kinase-3 alpha
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLa Universidad Complutense de Madrid
China Registration ClassN/A

Develop Information

Active CompaniesLa Universidad Complutense de Madrid
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A